This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Kaspersky Lab says US government violated its due process rights in software ban

( February 22, 2018, 23:55 GMT | Official Statement) -- MLex Summary: Kaspersky Lab has filed a motion for summary judgment that a decision by the US Department of Homeland Security to remove its software from government computers violated its Fifth Amendment right to due process, and that the DHS order is therefore invalid. "DHS has never claimed that the alleged 'information security risks' cited in the BOD were imminent, exigent, or urgent," Kaspersky said. "Many of the media reports cited by DHS in support of the BOD are several years old, and Plaintiffs’ software operates today in much the same way it always has. What has changed in 2017 is the increase in political scrutiny following Russia’s apparent interference in the 2016 presidential election, in which there is no allegation that Plaintiffs had any involvement."See documents below....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login